| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.087 | 0.2 |